uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
9.20
+0.17 (1.88%)
Mar 4, 2026, 11:47 AM EST - Market open
uniQure Market Cap
uniQure has a market cap or net worth of $573.08 million as of March 4, 2026. Its market cap has decreased by -17.09% in one year.
Market Cap
573.08M
Enterprise Value
480.28M
1-Year Change
-17.09%
Ranking
Category
Stock Price
$9.20
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $573.08M, an increase of 255.73%. That is a compound annual growth rate of 15.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 564.60M | -62.12% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 585.17M |
| Alto Neuroscience | 582.80M |
| LB Pharmaceuticals | 576.95M |
| Larimar Therapeutics | 573.36M |
| Design Therapeutics | 569.92M |
| Allogene Therapeutics | 564.07M |
| Replimune Group | 562.32M |
| CorMedix | 547.58M |